M. Sue O’Dorisio

8.8k total citations · 1 hit paper
161 papers, 5.5k citations indexed

About

M. Sue O’Dorisio is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, M. Sue O’Dorisio has authored 161 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Epidemiology, 70 papers in Oncology and 62 papers in Neurology. Recurrent topics in M. Sue O’Dorisio's work include Neuroendocrine Tumor Research Advances (79 papers), Neuroblastoma Research and Treatments (62 papers) and Lung Cancer Research Studies (48 papers). M. Sue O’Dorisio is often cited by papers focused on Neuroendocrine Tumor Research Advances (79 papers), Neuroblastoma Research and Treatments (62 papers) and Lung Cancer Research Studies (48 papers). M. Sue O’Dorisio collaborates with scholars based in United States, Germany and Switzerland. M. Sue O’Dorisio's co-authors include Thomas M. O’Dorisio, James R. Howe, Catherine L. Wood, Yusuf Menda, Aaron I. Vinik, S P Balcerzak, Herbert Chen, Rebecca S. Sippel, Ricardo V. Lloyd and Karel Pacák and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

M. Sue O’Dorisio

159 papers receiving 5.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

2013 563 citations M. Sue O’Dorisio, James R. Howe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Sue O’Dorisio United States	40	2.1k	1.9k	1.6k	1.5k	1.3k	161	5.5k
Håkan Ahlman Sweden	37	2.1k 1.0×	1.7k 0.9×	572 0.4×	1.5k 1.0×	348 0.3×	113	4.3k
Hans Scherübl Germany	45	1.6k 0.8×	2.0k 1.0×	2.3k 1.4×	818 0.5×	701 0.5×	154	5.3k
Federico Roncaroli United Kingdom	45	946 0.4×	712 0.4×	1.8k 1.1×	1.7k 1.1×	542 0.4×	210	7.2k
Yukitaka Ushio Japan	56	1.2k 0.6×	1.2k 0.6×	2.8k 1.7×	3.3k 2.2×	1.5k 1.1×	348	11.2k
Jun‐ichi Kuratsu Japan	40	960 0.5×	679 0.3×	1.1k 0.7×	2.0k 1.4×	478 0.4×	200	5.6k
Brian Harding United Kingdom	46	959 0.5×	1.0k 0.5×	2.8k 1.8×	806 0.5×	909 0.7×	162	6.9k
Louis Buscail France	51	2.4k 1.1×	3.3k 1.7×	3.2k 1.9×	864 0.6×	620 0.5×	177	7.6k
Keith M. Rich United States	44	1.0k 0.5×	554 0.3×	1.2k 0.7×	1.8k 1.2×	1.5k 1.2×	164	6.2k
J. Clay Goodman United States	41	1.1k 0.5×	861 0.4×	1.9k 1.2×	2.5k 1.6×	578 0.5×	141	6.0k
Albert H. Kim United States	44	1.0k 0.5×	821 0.4×	2.6k 1.6×	748 0.5×	876 0.7×	152	6.3k

Countries citing papers authored by M. Sue O’Dorisio

Since Specialization

Citations

This map shows the geographic impact of M. Sue O’Dorisio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sue O’Dorisio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sue O’Dorisio more than expected).

Fields of papers citing papers by M. Sue O’Dorisio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sue O’Dorisio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sue O’Dorisio. The network helps show where M. Sue O’Dorisio may publish in the future.

Co-authorship network of co-authors of M. Sue O’Dorisio

This figure shows the co-authorship network connecting the top 25 collaborators of M. Sue O’Dorisio. A scholar is included among the top collaborators of M. Sue O’Dorisio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Sue O’Dorisio. M. Sue O’Dorisio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fath, Melissa A., Stephen A. Graves, Zeb R. Zacharias, et al.. (2025). Targeting CXCR4 with 212Pb/203Pb-Pentixather Significantly Increases Overall Survival in Small Cell Lung Cancer. Radiation Research. 204(3). 173–183.

Fath, Melissa A., Dijie Liu, Stephen A. Graves, et al.. (2023). Abstract 5034: Targeting CXCR4 and thioredoxin reductase in high grade neuroendocrine tumors and neuroendocrine carcinomas. Cancer Research. 83(7_Supplement). 5034–5034. 1 indexed citations

Pollard, Janet H., Yusuf Menda, K. D. Zamba, et al.. (2021). Potential for Increasing Uptake of Radiolabeled ⁶⁸ Ga-DOTATOC and ¹²³ I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat. Cancer Biotherapy and Radiopharmaceuticals. 36(8). 632–641. 11 indexed citations

Cattaneo, Marco, Lawrence Dierickx, Péter Igaz, et al.. (2021). Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers. 13(24). 6290–6290. 7 indexed citations

Menda, Yusuf, Mark T. Madsen, Thomas M. O’Dorisio, et al.. (2018). ⁹⁰Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy. Journal of Nuclear Medicine. 59(11). 1692–1698. 36 indexed citations

Madsen, Mark T., Yusuf Menda, Thomas M. O’Dorisio, & M. Sue O’Dorisio. (2018). Technical Note: Single time point dose estimate for exponential clearance. Medical Physics. 45(5). 2318–2324. 65 indexed citations

Menda, Yusuf, Thomas M. O’Dorisio, James R. Howe, et al.. (2017). Localization of Unknown Primary Site with ⁶⁸Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor. Journal of Nuclear Medicine. 58(7). 1054–1057. 33 indexed citations

Sherman, Scott K., Jessica E. Maxwell, M. Sue O’Dorisio, Thomas M. O’Dorisio, & James R. Howe. (2014). Pancreastatin Predicts Survival in Neuroendocrine Tumors. Annals of Surgical Oncology. 21(9). 2971–2980. 56 indexed citations

Carr, Jennifer C., Scott K. Sherman, Donghong Wang, et al.. (2013). Overexpression of Membrane Proteins in Primary and Metastatic Gastrointestinal Neuroendocrine Tumors. Annals of Surgical Oncology. 20(S3). 739–746. 17 indexed citations

10.

Khanna, Geetika, M. Sue O’Dorisio, Yusuf Menda, et al.. (2007). Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies. Pediatric Blood & Cancer. 50(3). 561–566. 11 indexed citations

11.

Fabricius, Dorit, M. Sue O’Dorisio, Sue Blackwell, & Bernd Jahrsdörfer. (2006). Human Plasmacytoid Dendritic Cell Function: Inhibition of IFN-α Secretion and Modulation of Immune Phenotype by Vasoactive Intestinal Peptide. The Journal of Immunology. 177(9). 5920–5927. 36 indexed citations

12.

Bushnell, David, Yusuf Menda, Thomas M. O’Dorisio, et al.. (2004). Effects of Intravenous Amino Acid Administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher™]) Treatment. Cancer Biotherapy and Radiopharmaceuticals. 19(1). 35–41. 15 indexed citations

13.

Balster, Douglas A., et al.. (2002). Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1. Regulatory Peptides. 109(1-3). 155–165. 12 indexed citations

14.

Frühwald, Michael C., M. Sue O’Dorisio, Zunyan Dai, et al.. (2001). Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes Chromosomes and Cancer. 30(1). 38–47. 3 indexed citations

15.

Lara-Marquez, Maria Luz, M. Sue O’Dorisio, Thomas M. O’Dorisio, Manisha H. Shah, & Bahri Karaçay. (2001). Selective Gene Expression and Activation-Dependent Regulation of Vasoactive Intestinal Peptide Receptor Type 1 and Type 2 in Human T Cells. The Journal of Immunology. 166(4). 2522–2530. 93 indexed citations

16.

Levine, Edward A., Thomas M. O’Dorisio, James C. Watson, et al.. (1999). Intraoperative Gamma Detection Of125I-Lanreotide in Women With Primary Breast Cancer. Annals of Surgical Oncology. 6(4). 367–372. 13 indexed citations

17.

Rosenberg, Robert B., et al.. (1994). Modulation of Cyclic Guanosine Monophosphate Production during Escherichia coli Septic Shock. Biochemical Medicine and Metabolic Biology. 51(2). 149–155. 11 indexed citations

18.

McArthur, K.E., et al.. (1987). Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking. American Journal of Physiology-Gastrointestinal and Liver Physiology. 252(3). G404–G412. 9 indexed citations

19.

O’Dorisio, M. Sue, et al.. (1985). Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).. The Journal of Immunology. 134(6). 4078–4086. 45 indexed citations

20.

Wood, Catherine L. & M. Sue O’Dorisio. (1985). Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.. Journal of Biological Chemistry. 260(2). 1243–1247. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact